Neuroleptic malignant syndrome and Urine discoloration

Summary:

Urine discoloration is reported only by a few people with Neuroleptic malignant syndrome.

The study analyzes which people have Urine discoloration with Neuroleptic malignant syndrome. It is created by eHealthMe based on 1 person who has Urine discoloration and Neuroleptic malignant syndrome from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

1 person who has Neuroleptic Malignant Syndrome and Urine Discoloration is studied.

What is Neuroleptic malignant syndrome?

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents) is found to be associated with 1,119 drugs and 716 conditions by eHealthMe.

What is Urine discoloration?

Urine discoloration is found to be associated with 704 drugs and 69 conditions by eHealthMe.

Number of Urine discoloration in Neuroleptic malignant syndrome reports submitted per year:

Would you have Urine discoloration when you have Neuroleptic malignant syndrome?

Gender of people who have Neuroleptic Malignant Syndrome and experienced Urine Discoloration *:

female: 0.0 %
male: 100 %

Age of people who have Neuroleptic Malignant Syndrome and experienced Urine Discoloration *:

Common drugs taken by these people *:

Lovenox: 1 person, 100.00%
Dantrium: 1 person, 100.00%
Bromocriptine Mesylate: 1 person, 100.00%

Common symptoms for these people *:

Faeces Discolored: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urine discoloration?

Check whether Urine discoloration is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .

Related studies

Treatments, associated drugs and conditions:

Neuroleptic malignant syndrome (14,359 reports)
Urine discoloration (2,989 reports)

COVID vaccines that are related to Urine discoloration:

Common drugs associated with Urine discoloration:

Baycol: 461 reports
Rezulin: 248 reports
Zocor: 109 reports

All the drugs that are associated with Urine discoloration:

Urine discoloration (704 drugs)

All the conditions that are associated with Urine discoloration:

Urine discoloration (69 conditions)

How the study uses the data?

The study is based on Urine discoloration and Neuroleptic malignant syndrome, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.